Advertisement

Chronic Kidney Disease

  • Farahnak Assadi

Abstract

A 10-year old African-American girl has progressive kidney failure from biopsyproven FSGS. Her current serum creatinine is 3.7 mg/dl and estimated GFR is 16 ml/min/1.73m2. A urine protein-to-creatinine ratio is 4560 mg/g. Other medical problems include hypertension, currently treated with furosemide 40 mg orally twice daily and lisinopril 40 mg once daily. Her BP is 160/85 mmHg.

Keywords

Chronic Kidney Disease Correct Answer Autosomal Dominant Polycystic Kidney Disease Polycystic Kidney Disease Pediatric Nephrology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barkis GL, Weir MR, Seic M, et al. (2004) Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 65:1991–2002CrossRefGoogle Scholar
  2. Collins AJ, Li S, Gilbertson DT, et al. (2003) Chronic kidney disease and cardiovascular disease in Medicare population. Kidney Int 87:S24–S31CrossRefGoogle Scholar
  3. Ritz E, McClellan W (2004) Overview: Increased cardiovascular risk in patients with minor renal dysfunction: An emerging issue with far-reaching consequences. J Am Soc Nephrol 15: 513–516CrossRefPubMedGoogle Scholar
  4. Romundstad S, Holmen J, Kvenlid K, et al. (2003) Microalbuminuria and all-cause mortality in 2089 apparently healthy individuals: a 4.4-yrat follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 42:466–473CrossRefPubMedGoogle Scholar
  5. Muntner PLLH, Kusek JW, Chen J, et al. (2004) The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140:9–17PubMedGoogle Scholar
  6. Fogo AG (2003) Hypertensive risk factors in kidney disease in African Americans. Kidney Int 63:2331–2341CrossRefGoogle Scholar
  7. Wright JT, Glassock R, Herbet I, et al. (2002) Effect of BP lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288:2421–2431CrossRefPubMedGoogle Scholar
  8. Hogg RJ, Portman RJ, Millimer D (2000) Evaluation of proteinuria and nephritic syndrome in children: Recommendations from a pediatric nephrology panel established at National Kidney Foundation conference on proteinuria, albuminuria, risk, detection, and elimination (PARDE). Pediatrics 105:1242–1249CrossRefPubMedGoogle Scholar
  9. Ruggenenti P, Perna A, Remuzzi (2003) Retarding the progression of chronic renal disease: The neglected issue of residual proteinuria. Kidney Int 63:2254–2261CrossRefPubMedGoogle Scholar
  10. Baigent C, Landry M (2003) Study of Heart and Renal Protection (SHARP). Kidney Int 63: S207–S210CrossRefGoogle Scholar
  11. Cigarroa RG, Lange RA, Williams RH (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649–652CrossRefPubMedGoogle Scholar
  12. Nakao N, Yoshimma A, Morita H, et al. (2002) Combination therapy of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in non-diabetic renal disease: A randomized, controlled trial in Japan (CCPERATE). Lancet 361:117–124CrossRefGoogle Scholar
  13. Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Is this a cause for concern? Arch Intern Med 160:685–693CrossRefPubMedGoogle Scholar
  14. Ecder T, Edelstein CL, Fick-Brosnahan GM, et al. (2001) Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol 21:98–103CrossRefPubMedGoogle Scholar
  15. National Kidney Foundation: K/DOQI clinical guidelines for chronic kidney disease: evaluation, classification, and stratification (2002). Am J Kidney Dis 29 (Suppl 1) S1–S266Google Scholar
  16. Arora P, Obrador GT, Ruthazer R, et al. (1999) Prevalence, predictor, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10:1281–1286PubMedGoogle Scholar
  17. Hales CN (2001) Suicide of the nephron. Lancet 357:136–137CrossRefPubMedGoogle Scholar
  18. Keane WF (2000) Proteinuria: its clinical importance and role in progressive renal disease. Am J Kidney Dis 35:S97–S105CrossRefPubMedGoogle Scholar
  19. Levey AS, Greene T, Beck GJ, et al. (1999) Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? J Am Soc Nephrol 10:2436–2439Google Scholar
  20. Pedrini MT, Levey AS, Lau J, et al. (1996) The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: a meta-analysis. An Intern Med 124:267–637Google Scholar
  21. Cameron J (1999) European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 14:S61–S65CrossRefGoogle Scholar
  22. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002). Am J Kid Dis 39:S1–S266Google Scholar
  23. Hayashi T, Suzuki A, Shoji T, et al. (2000) Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35:250–256CrossRefPubMedGoogle Scholar
  24. Levin A, Thompson C, Ethier J, et al. (1999) Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34:125–134CrossRefPubMedGoogle Scholar
  25. Levin A, Thompson C, Ethier J, et al. (1999) Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kid Dis 34:125–134CrossRefPubMedGoogle Scholar
  26. Ritz E, Orth SR (1999) Nephropathy in patients with Type 2 diabetes mellitus. N Engl J Med 341:1127–1951CrossRefPubMedGoogle Scholar
  27. Slatopolsky E, Burke SK, Dillon MA, et al. (1999) Renagel, a nonabsorbed calcium-and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 55:299–307CrossRefPubMedGoogle Scholar
  28. Caravaca F, Arrobas M, Pizarro JL, et al. (1999) Metabolic acidosis in advanced renal failure: Differences between diabetic and nondiabetic patients. Am J Kidney Dis 33:892–898CrossRefPubMedGoogle Scholar
  29. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002). Am J Kidney Dis 39: S1–S266CrossRefGoogle Scholar
  30. Hels CN (2001) Suicide of the nephron. Lancet 357:136–137CrossRefGoogle Scholar
  31. Nath K (1998) The tubulointerstitium in progressive renal disease. Kidney Int 54:992–1456CrossRefPubMedGoogle Scholar
  32. Nakao N. Yoshimura A, Morita H, et al. (2003) Combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in no-diabetic renal disease (CCPERATE): a randomized controlled trial. Lancet 361:117–124CrossRefPubMedGoogle Scholar
  33. Dillon JJ (2001) Treating IgA nephropathy. J Am Soc Nephrol 2001; 12:846–847Google Scholar
  34. Ibanez L, Morlans M, Vidal X, et al. (2005) Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renalGoogle Scholar
  35. Besarab A, Bolton WK, Browne JK (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584–590CrossRefPubMedGoogle Scholar
  36. K/DOQI Clinical Practice Guidelines on Hypertension and antihypertensive agents in chronic kidney disease (2004). Am J Kidney Dis 43:(Suppl 1) S5–S10Google Scholar
  37. Knoll GA, Sahgal A, Nair RC, et al. (2002) Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med 112:110–114CrossRefPubMedGoogle Scholar
  38. Mitch WE, Remuzzi G (2004) Diets for patients with chronic kidney disease, still worth prescribing. J Am Soc Nephrol 15:234–237CrossRefPubMedGoogle Scholar
  39. Weiner DE, Sarnak MJ (2004) Managing dyslipidemia in chronic kidney disease. J Gen Intern Med 19:1045–1052CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Farahnak Assadi
    • 1
  1. 1.Rush University Medical CenterChicago

Personalised recommendations